Stelara 90MG/ML SYR 1S
Ended Awarded Last action
- Contract number
- SPE2DR26FBTMS
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $82,921
Award facts
- Contract value 100% obligated
- $82,920.65 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a delivery order valued at $82,920.65 to DMS Pharmaceutical Group Inc. for STELARA 90MG/ML syringes on February 4, 2026, with an ultimate completion date of February 6, 2026. This firm fixed-price delivery order carries no set-aside designation and is being performed in Park Ridge, Illinois. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler and registered federal contractor since 2001, was selected to supply this biologic immunosuppressant medication to support Department of Defense medical supply requirements.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to provide comprehensive pharmaceutical products and medical consumables to military healthcare facilities worldwide. The underlying IDC, valued at $499,999,999 and extending through December 31, 2036, positions DMS Pharmaceutical Group as a critical regional prime vendor contractor capable of delivering diverse specialized pharmaceutical requirements across the federal military medical system. The company's extensive product portfolio and demonstrated performance on numerous prior delivery orders for oncology treatments, biologics, vaccines, and specialty medications support its role as a strategic supplier within the DoD pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DR26FBTMS?
SPE2DR26FBTMS was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on February 4, 2026.
How much is contract SPE2DR26FBTMS worth?
The government has obligated $82,921 on SPE2DR26FBTMS.
Is contract SPE2DR26FBTMS an order under another contract?
Yes. SPE2DR26FBTMS is a delivery order under SPE2DR25D9628, an indefinite delivery contract.
Was contract SPE2DR26FBTMS competed?
The extent of competition for SPE2DR26FBTMS was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award